Timed walk as primary outcome measure of treatment response in clinical trials for HTLV-1-associated myelopathy: a feasibility study

BACKGROUND: To advance the treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP), randomised controlled therapeutic studies with appropriate and sensitive outcomes are reuired. One candidate outcome is the 10-metre walk test (10MWT), a patient-centred, simple and functiona...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pilot Feasibility Stud
Main Authors: Martin, Fabiola, Inoue, Eisuke, Cortese, Irene C. M., de Almeida Kruschewsky, Ramon, Adonis, Adine, Grassi, Maria Fernanda Rios, Galvão-Castro, Bernardo, Jacobson, Steven, Yamano, Yoshihisa, Taylor, Graham P., Bland, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5153909/
https://ncbi.nlm.nih.gov/pubmed/27965813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40814-015-0031-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados